Holen Sie sich die Stockscreener-App
16.68
0.42%
0.07
Handel nachbörslich:
16.68
Schlusskurs vom Vortag:
$16.61
Offen:
$16.46
24-Stunden-Volumen:
195.80K
Relative Volume:
0.47
Marktkapitalisierung:
$766.56M
Einnahmen:
$681.50M
Nettoeinkommen (Verlust:
$15.70M
KGV:
49.06
EPS:
0.34
Netto-Cashflow:
$36.60M
1W Leistung:
-4.08%
1M Leistung:
+9.74%
6M Leistung:
-25.93%
1J Leistung:
-12.26%
1-Tages-Spanne:
$16.46
$16.78
1-Wochen-Bereich:
$16.35
$17.54
52-Wochen-Spanne:
$14.98
$25.36
Avanos Medical Inc Stock (AVNS) Company Profile
Firmenname
Avanos Medical Inc
Sektor
Branche
Telefon
844-428-2667
Adresse
5405 WINDWARD PARKWAY, ALPHARETTA, GA
Vergleichen Sie AVNS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVNS
Avanos Medical Inc
|
16.68 | 766.56M | 681.50M | 15.70M | 36.60M | 0.34 |
|
ABT
Abbott Laboratories
|
131.44 | 227.98B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.98 | 156.20B | 16.75B | 1.85B | 1.89B | 1.25 |
|
SYK
Stryker Corp
|
390.48 | 148.86B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
91.20 | 116.94B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.91 | 41.82B | 6.60B | 4.16B | 490.10M | 6.93 |
Avanos Medical Inc Stock (AVNS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-25 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-22 | Eingeleitet | CL King | Buy |
| 2021-08-04 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-04-13 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-11-07 | Herabstufung | Stifel | Buy → Hold |
| 2019-11-06 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2018-10-16 | Eingeleitet | Barclays | Equal Weight |
| 2018-08-21 | Hochstufung | Raymond James | Mkt Perform → Outperform |
Alle ansehen
Avanos Medical Inc Aktie (AVNS) Neueste Nachrichten
Avanos Medical (AVNS) Expected to Announce Earnings on Tuesday - MarketBeat
USFDA Identifies Recall Of Avanos Medical's Respiratory Systems As Most Serious - BW Healthcare World
Avanos Medical, Inc. (NYSE:AVNS) Short Interest Update - MarketBeat
Radiofrequency Ablation Devices For Pain Management Market - openPR
Lacklustre Performance Is Driving Avanos Medical, Inc.'s (NYSE:AVNS) Low P/S - Simply Wall St
Avanos Medical (AVNS) Soars 7.2%: Is Further Upside Left in the Stock? - MSN
Avanos (AVNS) Declined due to Reduced Earnings Guidance - MSN
Avanos Medical (NYSE:AVNS) Stock Price Up 6.5%Should You Buy? - MarketBeat
Why Avanos Medical, Inc. (NYSE:AVNS) Could Be Worth Watching - Yahoo Finance
Tributary Capital Management LLC Purchases 246,379 Shares of Avanos Medical, Inc. (NYSE:AVNS) - MarketBeat
Trading (AVNS) With Integrated Risk Controls - Stock Traders Daily
Reasons to Hold Avanos Medical Stock in Your Portfolio Now - Yahoo Canada Finance
JPMorgan Chase & Co. Grows Stake in Avanos Medical, Inc. (NYSE:AVNS) - Defense World
Avanos Medical (NYSE:AVNS) Issues Q4 2024 Earnings Guidance - MarketBeat
Long Term Trading Analysis for (AVNS) - Stock Traders Daily
Avanos Medical (NYSE:AVNS) Updates Q4 Earnings Guidance - MarketBeat
Avanos Medical Highlights Strategic Transformation Initiatives - TipRanks
Avanos Medical (NYSE:AVNS) Reaches New 52-Week LowHere's What Happened - MarketBeat
Urea Breath Test Market Future Business Opportunities - openPR
Avanos Medical (NYSE:AVNS) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
Avanos Medical (NYSE:AVNS) Sets New 52-Week LowWhat's Next? - MarketBeat
AVNSAvanos Medical, Inc. Latest Stock News & Market Updates - StockTitan
Avanos Medical, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference - WV News
Avanos Medical CEO to Present at J.P. Morgan Healthcare Conference 2024 - StockTitan
Zacks Research Forecasts Weaker Earnings for Avanos Medical - Defense World
Avanos Medical FY2026 EPS Forecast Reduced by Zacks Research - MarketBeat
How the (AVNS) price action is used to our Advantage - Stock Traders Daily
Principal Financial Group Inc. Has $5.52 Million Stake in Avanos Medical, Inc. (NYSE:AVNS) - Defense World
Avanos Medical (NYSE:AVNS) Hits New 52-Week LowTime to Sell? - MarketBeat
United States Syringes, Needles and Urinary Catheters Market Outlook to 2033: A Comprehensive Analysis of Current Trends and Future Projections - GlobeNewswire Inc.
Geode Capital Management LLC Raises Position in Avanos Medical, Inc. (NYSE:AVNS) - Defense World
Jane Street Group LLC Has $1.58 Million Stock Position in Avanos Medical, Inc. (NYSE:AVNS) - Defense World
Barclays PLC Increases Stock Position in Avanos Medical, Inc. (NYSE:AVNS) - Defense World
Barclays PLC Acquires 78,583 Shares of Avanos Medical, Inc. (NYSE:AVNS) - MarketBeat
Avanos Medical stock hits 52-week low at $15.86 By Investing.com - Investing.com Nigeria
Avanos Medical stock hits 52-week low at $15.86 - Investing.com
Avanos Medical (NYSE:AVNS) Reaches New 1-Year LowWhat's Next? - MarketBeat
Avanos Medical Launches New CORGRIP® SR - The Eastern Progress Online
What Is Avanos Medical, Inc.'s (NYSE:AVNS) Share Price Doing? - Simply Wall St
Avanos Medical's SWOT analysis: healthcare firm's stock faces transformation hurdles - Investing.com
Adult Feeding Tubes and Formula Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036 - GlobalData
Short Interest in Avanos Medical, Inc. (NYSE:AVNS) Rises By 11.3% - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stock Position in Avanos Medical, Inc. (NYSE:AVNS) - Defense World
BNP Paribas Financial Markets Has $406,000 Position in Avanos Medical, Inc. (NYSE:AVNS) - Defense World
Finanzdaten der Avanos Medical Inc-Aktie (AVNS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.38%
1.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):